Japan Veterinary Medicine Market Size & Outlook, 2026-2033
The veterinary medicine market in Japan is expected to reach a projected revenue of US$ 3,390.8 million by 2033. A compound annual growth rate of 10.3% is expected of Japan veterinary medicine market from 2026 to 2033.
Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago
Other key industry trends
In terms of revenue, Japan accounted for 3.0% of the global veterinary medicine market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China veterinary medicine market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,239.4 million by 2033.
The veterinary medicine market in Japan is anticipated to witness steady growth owing to the increasing number of cattle farms. The increasing livestock population is anticipated to drive market growth. In addition, growing pet healthcare expenditure and pet adoption in Japan are expected to drive the market.
For instance, Japan is the only other country in the world where pets outnumber children. According to the Japan Pet Food Association, there are over 20 million cats and dogs in the country and 17 million children under the age of 16 years. Government support and regulation for the welfare of animal health are anticipated to fuel the market in Japan.
For instance, Japan's Act of Welfare and Management of Animals (1973) focuses on building awareness among people as part of its process of implementation. Thus, growing awareness is expected to fuel the demand for veterinary medicine in the country, thereby boosting the market.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Medicine Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 64.86% in 2025.
Horizon Databook has segmented the Japan veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.
The veterinary medicine market in Japan is anticipated to witness steady growth owing to the increasing number of cattle farms. The increasing livestock population is anticipated to drive market growth. In addition, growing pet healthcare expenditure and pet adoption in Japan are expected to drive the market.
For instance, Japan is the only other country in the world where pets outnumber children. According to the Japan Pet Food Association, there are over 20 million cats and dogs in the country and 17 million children under the age of 16 years. Government support and regulation for the welfare of animal health are anticipated to fuel the market in Japan.
For instance, Japan's Act of Welfare and Management of Animals (1973) focuses on building awareness among people as part of its process of implementation. Thus, growing awareness is expected to fuel the demand for veterinary medicine in the country, thereby boosting the market.
Japan Veterinary Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
Biologics
Pharmaceuticals
Medicated Feed Additives
Japan Veterinary Medicine Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
Companion Animals
Production Animals
Japan Veterinary Medicine Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Other Routes
Injectable
Topical
Japan Veterinary Medicine Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
E-commerce
Offline Retail Stores
Others
Veterinary Hospitals & Clinics
Reasons to subscribe to Veterinary Medicine Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Medicine Market Outlook databook
Our clientele includes a mix of Veterinary Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Veterinary Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Veterinary Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Veterinary Medicine Market, 2021-2033 (US$M)